Literature DB >> 24289577

Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution.

Yu-Jie Zeng1, Lu Liu, Heng Wu, Wei Lai, Jie-Zhi Cao, He-Yang Xu, Jie Wang, Zhong-Hua Chu.   

Abstract

BACKGROUND: The gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) is the most common type of neuroendocrine neoplasm. We summarized data in our centre to investigate the clinicopathological features, diagnostic methods, therapeutic approaches and prognosis for this neoplasm to increase knowledge of this disease in Asian populations.
METHOD: A total of 122 patients treated at Sun Yet-san Memorial Hospital of Sun Yat-sen University between January 2000 and December 2011 were analyzed retrospectively.
RESULTS: Pancreas was the most common site of involvement (65/122, 53.3%); this disease has no special symptoms; positive rates of chromogranin A (CgA) and synaptophysin (Syn) were 81.1% and 87.7%, respectively. The positive rate of Syn had statistical difference among the three grades, but not CgA. Some 68 patients had G1 tumors, 32 G2 tumors and 22 G3 tumors, and Chi-square test showed that higher grading was correlated with worse prognosis (χ2=32.825, P=0.0001). A total of 32 patients presented with distant metastasis, and 8 cases emerged during following up. Cox proportional hazards regression modeling showed that the tumor grade (P=0.01), lymphatic metastasis (P=0.025) and distant metastasis (P=0.031) were predictors of unfavorable prognosis. The overall 5-year survival rate was 39.6%, the 5-year survival rate of G1 was 55.7%, and the G2 and G3 were 34.2% and 0%, respectively.
CONCLUSIONS: The incidence of gastroenteropancreatic neuroendocrine tumors has risen over the last 12 years. All grades of these diseases metastasize readily, and further research regarding the treatment of patients after radical surgery is needed to prolong disease-free survival.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24289577     DOI: 10.7314/apjcp.2013.14.10.5775

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Clinicopathological features and survival analysis of gastroenteropancreatic neuroendocrine neoplasms: a retrospective study in a single center of China.

Authors:  Xuelong Jiao; Yujun Li; Hongyan Wang; Shanglong Liu; Dongfeng Zhang; Yanbing Zhou
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

2.  Prognostic value of inflammation-based markers in advanced or metastatic neuroendocrine tumours.

Authors:  J Zou; Q Li; F Kou; Y Zhu; M Lu; J Li; Z Lu; L Shen
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

3.  Clinicopathologic profile of gastroenteropancreatic neuroendocrine neoplasms in a referral center of South India.

Authors:  Temjen Sunup Jamir; Bhawana Ashok Badhe; Norton Stephen; Bheemanathi Hanuman Srinivas; Biju Pottakkat
Journal:  Int J Clin Exp Pathol       Date:  2022-05-15

4.  Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.

Authors:  Meng Zhang; Ping Zhao; Xiaodan Shi; Ahong Zhao; Lianfeng Zhang; Lin Zhou
Journal:  BMC Endocr Disord       Date:  2017-07-13       Impact factor: 2.763

5.  Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series.

Authors:  Mitsuru Sugimoto; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Ko Watanabe; Jun Nakamura; Hitomi Kikuchi; Yuichi Waragai; Mika Takasumi; Satoshi Kawana; Yuko Hashimoto; Takuto Hikichi; Hiromasa Ohira
Journal:  World J Clin Oncol       Date:  2017-06-10

6.  Pancreatic Neuroendocrine Neoplasm Invading the Entire Main Pancreatic Duct Diagnosed by a Preoperative Endoscopic Biopsy.

Authors:  Tomoya Kimura; Mitsuru Sugimoto; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Jun Nakamura; Mika Takasumi; Minami Hashimoto; Tsunetaka Kato; Yasuhide Kofunato; Takashi Kimura; Shoki Yamada; Yuko Hashimoto; Shigeru Marubashi; Takuto Hikichi; Hiromasa Ohira
Journal:  Intern Med       Date:  2020-05-23       Impact factor: 1.271

7.  Clinical and pathological features of non-functional neuroendocrine tumors of pancreas: a report from iran.

Authors:  Neda Nozari; Sepideh Nikfam; Arash Nikmanesh; Mehdi Mohammadnejad; Rasoul Sotoudehmanesh; Farhad Zamani; Shahin Merat; Reza Malekzadeh; Akram Pourshams
Journal:  Middle East J Dig Dis       Date:  2014-07

8.  Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm.

Authors:  Huiying Shi; Chen Jiang; Qin Zhang; Cuihua Qi; Hailing Yao; Rong Lin
Journal:  Diagn Pathol       Date:  2020-09-11       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.